Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: A nationwide prescription database study

Clinical Epidemiology

Volumn 4, Issue 1, 2012, Pages 225-231

  Steffenak, Anne Kjersti Myhrene ^a   Wilde Larsson, Bodil ^a,b   Nordström, Gun ^a,b   Skurtveit, Svetlana ^c,d   Hartz, Ingeborg ^a  

^a INLAND NORWAY UNIVERSITY OF APPLIED SCIENCES   (Norway)

^b KARLSTAD UNIVERSITY   (Sweden)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Adolescents; Antianxiety agents; Antidepressive agents; Defined daily dose; Hypnotics; Long term use; Prescription database; Psychotropic drugs; Sedatives

Indexed keywords

ALIMEMAZINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BARBITAL; CITALOPRAM; CLOMETHIAZOLE; CLOMIPRAMINE; DOXEPIN; ESCITALOPRAM; FLUNITRAZEPAM; FLUOXETINE; FLUVOXAMINE; HYPNOTIC AGENT; MELATONIN; MIANSERIN; MIDAZOLAM; MIRTAZAPINE; MOCLOBEMIDE; NITRAZEPAM; NORTRIPTYLINE; PAROXETINE; PROMETHAZINE; PSYCHOTROPIC AGENT; SCOPOLAMINE; SERTRALINE; TRIMIPRAMINE; UNINDEXED DRUG; ZOLPIDEM; ZOPICLONE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DATA BASE; DRUG COST; DRUG MARKETING; DRUG USE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFORMATION RETRIEVAL; MALE; NORWAY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; SEX DIFFERENCE; SEX RATIO; TREND STUDY;

EID: 84866030841     PISSN: None     EISSN: 11791349     Source Type: Journal    
DOI: 10.2147/clep.s31624     Document Type: Article

References (30)

1. Zito J, Safer D, DosReis S, et al. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med. 2003;157:17-25.
2. Fegert J, Kolch M, Zito J, Glaeske G, Janhsen K. Antidepressant use in children and adolescents in Germany. J Child Adolesc Psychopharmacol. 2006;16:197-206.
3. Skurtveit S, Rosvold EO, Furu K. Use of psychotropic drugs in an urban adolescent population: the impact of health-related variables, lifestyle and sociodemographic factors. The Oslo Health Study 2000-2001. Pharmacoepidemiology and Drug Safety. 2005;14(4):277-283.
4. Zoëga H, Baldursson G, Hrafnkelsson B, Almarsdóttir AB, Valdimarsdóttir U, Halldórsson M. Psychotropic Drug Use among Icelandic Children: A Nationwide Population-Based Study. Journal of Child and Adolescent Psychopharmacology. 2009;19(6):757-764.
5. Hartz I, Furu K, Bratlid T, Skurtveit S. Increase in use of hypnotic drugs among children and adolescents aged 0-17 years-a nationwide prescription database study. Pharmacoepidemiolgy and Drug Safety. 2010;19:293.
6. Myhrene Steffenak AK, Nordström G, Wilde-Larsson B, Skurtveit S, Furu K, Hartz I. Mental Distress and Subsequent Use of Psychotropic Drugs Among Adolescents-A Prospective Register Linkage Study. The Journal of adolescent health: official publication of the Society for Adolescent Medicine. 2012;50(6):578-587.
7. Simeon JG, Wiggins DM, Williams E. World wide use of psychotropic drugs in child and adolescent psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 1995; 19(3):455-465.
8. Rothenberger A, Gerlach M, Dittmann RW. Psychotropic Drugs in Child and Adolescent Psychiatry-a New Era on the Horizon. Current Pharmaceutical Design. Jul;16(22):2395-2397.
9. Bazzano et al. Off-label prescribing to children in the United States outpatient setting. Academic Pediatrics. 2009;9(2):81-88.
10. Acquaviva E, Legleye S, Auleley GR, Deligne J, Carel D, Falissard BB. Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data. Bmc Psychiatry. Nov 2009:9.
11. Zito J, Safer D, Berg L, et al. A three-country comparison of psychotropic medication prevalence in youth. Child and Adolescent Psychiatry and Mental Health. 2008;2(1):26.
12. Zito J, Tobi H, Berg L, et al. Antidepressant prevalence for youths: a multi-national comparison. Pharmacoepidemiology and Drug Safety. 2006;15:793-798.
13. Furu K. Establishment of the nationwide Norwegian Prescription Database (NorPD)-new opportunities for research in pharmacoepidemiology in Norway. Norsk epidemiologi. 2008;18(2).
14. Who Collaborating Center for drug Statistics Methodology. The ATC/DDD Systen (Online). Available at: http://www.whocc.no/. Accessed March 23, 2011.
15. http://statbank.ssb.no//statistikkbanken/default_fr.asp?PLanguage=1. June 2012.
16. Hsia Y, Maclennan K. Rise in psychotropic drug prescribing in children and adolescents during 1992-2001: a population-based study in the UK. Eur J Epidemiol. 2009;24(4):211-216.
17. Hansen E, Holstein B, Due P. Time trends in medicine use among adolescents in industrialised countries. European Journal of Public Health. 2003;13:43.
18. Crowley SJ, Carskadon MA. Modifications to weekend recovery sleep delay circadian phase in older adolescents Chronobiology International. 2010;27(7):1469-1492.
19. Srinivasan V, Spence WD, Pandi-Perumal SR, Zakharia R, Bhatnagar KP, Brzezinski A. Melatonin and human reproduction: Shedding light on the darkness hormone. Gynecological Endocrinology. 2009;25(12):779-785.
20. Sutherland ER, Ellison MC, Kraft M, Martin RJ. Elevated serum melatonin is associated with the nocturnal worsening of asthma. Journal of Allergy and Clinical Immunology. 2003;112(3):513-517.
21. Hoebert M vdHK, van Geijlswijk IM, Smits MG. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res. 2009;47(1):1-7.
22. Ingeborg M van Geijlswijk, Robert H Mol, Toine CG Egberts, Smits MG. Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia. Psychopharmacology. 2011;216(1):111-120.
23. Dekker et al van Lang ND, Bongers IL, van der Ende J, Verhulst FC. Developmental trajectories of depressive symptoms from early childhood to late adolescence: gender differences and adult outcome. J Child Psychol Psychiatry. 48(7):657-666.
24. Olfson M, Shaffe D, Marcus SC, Greenberg T. Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents. Arch Gen Psychiatry. 2003;60(10):978-982.
25. Clavenna A et al. Use of psychotropic medications in Italian children and adolescents. Eur J pediatr. 2007(166): 4, 399-347.
26. Clavenna A, Bonati M, Rossi E, De Rosa M. Increase in non-evidence based use of antidepressants in children is cause for concern (letter). BMJ. 2004;328:711-712.
27. Bramnes et al, Use of antidepressants among children and adolescents 2004-06-did the warnings lead to fewer prescriptions? (Antidepressiver hos barn og ungdom-førte advarsler til færre forskrivninger?). Tidsskriftet for Den norske legeforening 20, 127; 2653-2655.
28. Skurtveit S, Selmer R, Tverdal A, Furu K. The validity of self-reported prescription medication use among adolescents varied by therapeutic class. Journal of Clinical Epidemiology. 2008;61(7):714-717.
29. Nielsen MW, Søndergaard B, Kjøller M, Hansen EH. Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic group. Journal of Clinical Epidemiology. 2008;61(9):919-924.
30. Apa-Hall P, Scwartz-Bloom RD, McConnell ES. The current state of teenage drug abuse: trend toward prescription drugs. The Journal of School Nursing, supplement. 2008:15.